BSX(Boston Scientific Corporation) 的财务报表:医疗保健,医疗器械。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $11.89B | $12.68B | $14.24B | $16.75B | $20.07B |
| 毛利润 | $8.18B | $8.73B | $9.90B | $11.49B | $13.85B |
| 营业利润 | $1.20B | $1.65B | $2.34B | $2.60B | $3.61B |
| 净利润 | $1.04B | $698.00M | $1.59B | $1.85B | $2.89B |
| 经营现金流 | $1.87B | $1.53B | $2.50B | $3.44B | $4.53B |
| 自由现金流 | $1.32B | $938.00M | $1.79B | $2.65B | $3.66B |
| 摊薄每股收益 | $0.69 | $0.45 | $1.07 | $1.25 | $1.94 |